UCB Staves Off Seizure Drug Competition After Bench Trial
UCB Inc. has persuaded a Delaware federal judge to uphold patents covering its seizure medication Nayzilam, a major win given that generic-drug maker Cipla Ltd. already admitted to infringement....To view the full article, register now.
Already a subscriber? Click here to view full article